tiprankstipranks
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market

BioCryst (BCRX) Cash flow

2,698 Followers

BioCryst Cash Flow

BCRX's free cash flow for Q4 2025 was $275.23M. For the 2025 fiscal year, BCRX's free cash flow was decreased by $380.56M and operating cash flow was $276.04M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ 329.88M$ -52.02M$ -95.14M$ -161.85M$ -142.16M
Investing Cash Flow
$ -13.69M$ 52.59M$ -131.50M$ -128.24M$ 15.80M
Financing Cash Flow
$ -332.44M$ -5.76M$ 32.48M$ 88.03M$ 359.67M
End Cash Position
$ 1.60M$ 106.32M$ 112.45M$ 306.24M$ 507.73M
Free Cash Flow
$ 327.41M$ -53.14M$ -97.31M$ -163.20M$ -144.54M
Currency in USD

BioCryst Cash Flow